<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 12 May 2026 19:51:22 -0400--><rss version="2.0">
    <channel>
        <title>Immunocore Holdings plc (IMCR) SEC Filings</title>
        <link>https://www.immunocore.com/investors/financials-filings/sec-filings/rss</link>
        <description>Immunocore Holdings plc (IMCR) - SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_b541aae032f58bf8fdbdeabb137fc49f/immunocore/files/theme/images/logo-sm.png</url>
                <title>Immunocore Holdings plc Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]></title>
                <description><![CDATA[4 Related Documents: S-8, EX-5.1, EX-23.1, EX-FILING FEES]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-019737/0001140361-26-019737.pdf</link>
                <pubDate>Fri, 08 May 26 08:18:12 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-019737/0001140361-26-019737.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-019205/0001140361-26-019205.pdf</link>
                <pubDate>Wed, 06 May 26 07:09:42 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-019205/0001140361-26-019205.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[4 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000009/0001671927-26-000009.pdf</link>
                <pubDate>Wed, 06 May 26 07:03:39 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000009/0001671927-26-000009.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[ARS - Annual Report to Security Holders]]></title>
                <description><![CDATA[ARS]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015125/0001140361-26-015125.pdf</link>
                <pubDate>Thu, 16 Apr 26 16:07:10 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015125/0001140361-26-015125.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[DEF 14A - Definitive proxy statements]]></title>
                <description><![CDATA[DEF 14A]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015122/0001140361-26-015122.pdf</link>
                <pubDate>Thu, 16 Apr 26 16:06:27 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-015122/0001140361-26-015122.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000149/0001974494-26-000149.pdf</link>
                <pubDate>Wed, 08 Apr 26 15:58:24 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000149/0001974494-26-000149.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[144 - Report of proposed sale of securities]]></title>
                <description><![CDATA[144]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000121/0001974494-26-000121.pdf</link>
                <pubDate>Wed, 11 Mar 26 13:48:00 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001974494-26-000121/0001974494-26-000121.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]></title>
                <description><![CDATA[SCHEDULE 13G/A]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001897612-26-000309/0001897612-26-000309.pdf</link>
                <pubDate>Tue, 14 Apr 26 14:27:35 -0400</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001897612-26-000309/0001897612-26-000309.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-006721/0001140361-26-006721.pdf</link>
                <pubDate>Wed, 25 Feb 26 07:31:00 -0500</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001140361-26-006721/0001140361-26-006721.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[6 Related Documents: 10-K, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1]]></description>
                <link>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000005/0001671927-26-000005.pdf</link>
                <pubDate>Wed, 25 Feb 26 07:02:00 -0500</pubDate>
                <guid>https://www.immunocore.com/investors/financials-filings/sec-filings/content/0001671927-26-000005/0001671927-26-000005.pdf</guid>
                                                                            </item>
            </channel>
</rss>